Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats
- DOI
- 10.15488/21481
- Published
- 2025
- Container
- Not recorded
- Publisher
- [Hoboken, NJ : Wiley]
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.15488/21481,
title = {Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats},
author = {Elbadawy, Hossein M. and Almikhlafi, Mohannad A. and Alsubhi, Mohammed H. and Shokry, Aya A. and Fayed, Hany M. and Mohamed, Bassim M. S. A. and Afifi, Sherif M. and Esatbeyoglu, Tuba and Korany, Reda M. S. and Elbaset, Marawan A.},
year = {2025},
doi = {10.15488/21481},
url = {https://doi.org/10.15488/21481}
}RIS
TY - JOUR TI - Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats AU - Elbadawy, Hossein M. AU - Almikhlafi, Mohannad A. AU - Alsubhi, Mohammed H. AU - Shokry, Aya A. AU - Fayed, Hany M. AU - Mohamed, Bassim M. S. A. AU - Afifi, Sherif M. AU - Esatbeyoglu, Tuba AU - Korany, Reda M. S. AU - Elbaset, Marawan A. PY - 2025 DO - 10.15488/21481 UR - https://doi.org/10.15488/21481 ER -
APA
M., E. H., A., A. M., H., A. M., A., S. A., M., F. H., A., M. B. M. S., M., A. S., Tuba, E., S., K. R. M., & A., E. M. (2025). Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats. https://doi.org/10.15488/21481
Source records
- datacite · retrieved 2026-09-25T16:29:58.413Z